Reordering the pecking order: management describes the company winning on a stage where it used to be too small to play
The model's full reasoning — Q1 2018 call → NOWe need to determine if management describes the company as now competing and winning at a level of the market that used to be above it. The question asks: does management convey that the company has recently begun to be treated as a legitimate contender in situations, against rivals, or for business that previously would have gone to bigger, more established, or more entrenched players, and that this has already produced real results in the current period? We need to look for a change in tier, already real, and early. The transcript is about Illumina's Q1 2018 earnings call. Illumina is a major player in genomics sequencing. The question is whether they describe moving up a tier. Let's scan the transcript for any such description. Management talks about strong growth, consumables, NovaSeq, etc. They mention partnerships with Loxo Oncology and BMS for companion diagnostics. They mention FDA approvals, CMS coverage decisions. They talk about consumer genomics with 23andMe. But do they say that they are now competing at a level they previously couldn't? They are already a dominant player in sequencing. They might be expanding into new areas, but is that a tier change? The question is about being treated as a legitimate contender for business that previously would have gone to bigger, more established players. Illumina is already the leader in sequencing. So they are not moving up a tier; they are already at the top. They might be entering new markets like clinical diagnostics, but they are already a major player. The transcript does not explicitly say "we are now competing at a level we previously couldn't" or "we are now being considered for deals that used to go to others." They talk about partnerships and regulatory approvals, but that is not necessarily a tier change. They are already a leading company. So the answer is likely NO. But let's check if there is any specific mention of moving up. For example, they mention that NovaSeq is democratizing access, but that is about enabling customers, not about Illumina's own tier. They mention that they are partnering with pharma companies, but they are already a major supplier. They don't say they are now winning business they previously couldn't. They might be expanding into clinical diagnostics, but they are already a major player there.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
PRIM · Q2 2018 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing exactly this tier shift in the T&D segment: after the Willbros acquisition, the group “has been able to sign new awards with customers that have been hesitant because of previous concerns about their financial viability” and has received work from “some of the largest electrical utilities in the country.” David King notes that the work “outpaces anything he has seen in his 40-plus years,” and Pete Moerbeek adds that the one-year MSA revenue alone is now $1.1 million. Management presents these wins as a direct result of Primoris’s financial strength and parent-company backing, which previously excluded the T&D business from the largest accounts. The commentary frames the development as newly enabled and still early (only one month of T&D performance), satisfying all three required elements: a clear change in competitive tier, real business already won, and contribution still incremental relative to the company’s prior scale.
SANG · Q2 2024 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing a shift to competing at a higher tier with sophisticated mid-market clients through bundled offerings, illustrated by a recent win with a statewide park department that larger vendors couldn't serve affordably. They explicitly note this represents a change in tier ("the type of client the bundled capabilities of Sangoma can reach ... Sangoma is well positioned to play in both the small market and more sophisticated mid-market") and that it has already produced real results ("this recent win"), while conveying it is early ("there'll be a lag before it delivers material results.
WD · Q2 2022 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management explicitly describing a tier shift: from competing "predominantly with the likes of JPMorgan and Wells Fargo" to "going head-to-head with CBRE and JLL," enabled by technology investments that now allow them to "successfully compete against these much larger firms.